15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33222668 | OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction. | 2021 | 2 |
2 | 30650200 | Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes. | 2019 Mar | 5 |
3 | 27002938 | A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies. | 2016 Apr 12 | 1 |
4 | 27212159 | Inhibition of mTOR suppresses human gallbladder carcinoma cell proliferation and enhances the cytotoxicity of 5-fluorouracil by downregulating MDR1 expression. | 2016 May | 1 |
5 | 27358039 | Inhibition of JNK-mediated autophagy enhances NSCLC cell sensitivity to mTORC1/2 inhibitors. | 2016 Jun 30 | 1 |
6 | 26026051 | Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells. | 2015 Aug | 3 |
7 | 26213847 | OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo. | 2015 Sep 22 | 1 |
8 | 26284306 | The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2. | 2015 Oct | 2 |
9 | 22080480 | Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies. | 2012 Jan 12 | 1 |
10 | 22476852 | Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. | 2012 Aug | 1 |
11 | 21363918 | Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. | 2011 Mar 1 | 1 |
12 | 21415215 | Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors. | 2011 Jul 1 | 1 |
13 | 21673091 | Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin. | 2011 Aug | 3 |
14 | 20616057 | Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells. | 2010 Jul 13 | 1 |
15 | 20699667 | Induction of autophagy by dual mTORC1-mTORC2 inhibition in BCR-ABL-expressing leukemic cells. | 2010 Oct | 1 |